Raymond James & Associates Has $12.95 Million Stake in Koninklijke Philips (NYSE:PHG)

Raymond James & Associates increased its stake in Koninklijke Philips (NYSE:PHG) by 6.7% in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 513,922 shares of the technology company’s stock after purchasing an additional 32,399 shares during the quarter. Raymond James & Associates owned approximately 0.05% of Koninklijke Philips worth $12,951,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in PHG. Mondrian Investment Partners LTD lifted its stake in shares of Koninklijke Philips by 45.1% in the first quarter. Mondrian Investment Partners LTD now owns 9,553,058 shares of the technology company’s stock worth $191,061,000 after buying an additional 2,971,008 shares during the last quarter. Jane Street Group LLC boosted its holdings in Koninklijke Philips by 361.7% during the first quarter. Jane Street Group LLC now owns 629,136 shares of the technology company’s stock valued at $12,583,000 after acquiring an additional 492,881 shares during the period. Russell Investments Group Ltd. boosted its holdings in Koninklijke Philips by 85.6% during the fourth quarter. Russell Investments Group Ltd. now owns 1,033,823 shares of the technology company’s stock valued at $24,119,000 after acquiring an additional 476,907 shares during the period. Brandes Investment Partners LP grew its position in shares of Koninklijke Philips by 48.7% in the fourth quarter. Brandes Investment Partners LP now owns 1,285,935 shares of the technology company’s stock valued at $30,001,000 after purchasing an additional 421,055 shares during the last quarter. Finally, OLD Mission Capital LLC lifted its position in shares of Koninklijke Philips by 434.9% during the 4th quarter. OLD Mission Capital LLC now owns 434,282 shares of the technology company’s stock worth $10,132,000 after purchasing an additional 353,096 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Stock Up 1.0 %

Shares of PHG stock opened at $30.17 on Friday. The stock has a market cap of $28.36 billion, a P/E ratio of -31.43, a price-to-earnings-growth ratio of 1.00 and a beta of 0.72. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. The stock has a fifty day moving average price of $27.12 and a 200 day moving average price of $24.32. Koninklijke Philips has a one year low of $17.75 and a one year high of $30.18.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings data on Monday, July 29th. The technology company reported $0.32 EPS for the quarter. The company had revenue of $4.80 billion during the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. Analysts predict that Koninklijke Philips will post 1.5 earnings per share for the current year.

Wall Street Analysts Forecast Growth

PHG has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. BNP Paribas upgraded shares of Koninklijke Philips from an “underperform” rating to a “neutral” rating in a research note on Tuesday, May 7th. UBS Group upgraded shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a research report on Tuesday, April 30th. Sanford C. Bernstein raised shares of Koninklijke Philips from a “market perform” rating to an “outperform” rating in a research report on Monday, May 13th. Finally, StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Monday, July 15th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Koninklijke Philips presently has a consensus rating of “Hold”.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.